Thiel Bio
Overview
Thiel Bio is a venture capital fund focused on investments in the biotechnology and life sciences sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| HistoSonics | Oct 2025 | Private Equity | Co-investor |
| Peptilogics | Oct 2025 | Series B Extension | Lead |
| Network Bio | Aug 2026 | Seed | Co-investor |
| Ataraxis AI | Mar 2025 | Series A | Co-investor |
| EnClear Therapies | Sep 2024 | VC Round | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Thiel Bio based?
Thiel Bio is headquartered in West Hollywood, California, United States.
When was Thiel Bio founded?
Thiel Bio was founded in 2023.
How many portfolio companies does Thiel Bio have?
Thiel Bio has 5 portfolio companies in Caplight's dataset.
What are some companies in Thiel Bio's portfolio?
Portfolio companies visible on Caplight include HistoSonics, Peptilogics, Network Bio, Ataraxis AI, EnClear Therapies.
What was Thiel Bio's most recent investment shown here?
Thiel Bio's most recent investment in this portfolio sample was in Network Bio in 2026.
What sectors does Thiel Bio focus on?
Thiel Bio focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does Thiel Bio focus on?
Stage focus information for Thiel Bio is not publicly available.
What is Thiel Bio's AUM?
Thiel Bio's assets under management are estimated between $91.3M and $100.0M.